2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Neoplasms
4
Breast Neoplasms
4
Melanoma
3
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Healthy Participants
2
Advanced Solid Tumor
2
cMET-dysregulated Advanced Solid Tumors
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Solid Tumor, Adult
1
Solid Tumor
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Liver Cirrhosis
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Head and Neck Neoplasms
1
Drug-drug Interaction,SHR3680
1
Colorectal Neoplasms
1
Advanced Solid Malignancies
1
Advanced Pancreatic Cancer
1
Interventions
Magnetic Resonance Spectroscopy
10
Iodine-131
8
selpercatinib
5
Thyrotropin Alfa
5
trametinib
4
dabrafenib
4
Vemurafenib
4
Thyroidectomy
4
lenvatinib
3
cabozantinib
3
Transurethral Resection of Prostate
3
Sunitinib
3
Specimen Handling
3
Sorafenib
3
Radiofrequency Ablation
3
Fluorodeoxyglucose F18
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
3
vandetanib
2
entrectinib
2
cobimetinib
2
X-Rays
2
Trastuzumab
2
Thyroid (USP)
2
Surgical Procedures, Operative
2
Rosiglitazone
2
Radiotherapy
2
Nivolumab
2
Lymph Node Excision
2
Interviews as Topic
2
Gefitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Cancer, Papillary
×
Digoxin
×
Clear all
NCT05507775
2024-04-11
DIGUP-TC
Radboud University Medical Center
Phase NA
Completed
8 enrolled